# Liste des Acronymes {.unnumbered}
<!-- Automatic sorting by sourcing script/sort_acronyms.R -->
```{=tex}
\begin{acronym}
\acro{1,24,25(OH)3D3}[1,24,25(OH)\textsubscript{3}D\textsubscript{3}]{1,24,25‐trihydroxycholécalciférol}
\acro{1,25(OH)2D3}[1,25(OH)\textsubscript{2}D\textsubscript{3}]{1,25-dihydroxycholécalciférol\acroextra{ (calcitriol)}}
\acro{7-DHC}{7-déhydrocholestérol}
\acro{24,25(OH)2D3}[24,25(OH)\textsubscript{2}D\textsubscript{3}]{24,25-dihydroxycholécalciférol}
\acro{25(OH)D3}[25(OH)D\textsubscript{3}]{25-hydroxycholécalciferol\acroextra{ (calcidiol ou calcifédiol)}}
\acro{ACE}{enzyme de conversion de l'angiotensine}
\acro{ACE2}{enzyme de conversion de l'angiotensine 2}
\acro{ADAM17}{a disintegrin and metalloprotease 17}
\acro{ADN}{acide désoxyribonucléique}
\acro{AJR}{\LU{A}{a}pport \LU{J}{j}ournalier \LU{R}{r}ecommandé}
\acro{AMPK}{AMP-activated protein kinase}
\acro{Ang II}{angiotensine II}
\acro{Ang(1-7)}{angiotensine 1-7}
\acro{ANSES}{Agence Nationale de Sécurité sanitaire de l'alimentation, de l'Environnement et du Travail}
\acro{ANSM}{Agence Nationale de Sécurité des Médicaments}
\acro{AT1R}{récepteur de l'angiotensine II de type I}
\acro{CaMKKβ}{Ca$^{2+}$/calmodulin-dependent protein kinase kinase β}
\acro{CCR10}{C-C chemokine receptor type 10}
\acro{CD}{cluster de différenciation}
\acro{CIVD}{coagulation intravasculaire disséminée}
\acro{Cmax}[C\textsubscript{max}]{concentration maximale}
\acro{CMH-II}{\LU{C}{c}omplexe \LU{M}{m}ajeur d'\LU{H}{h}istocompatibilité de \LU{C}{c}lasse II}
\acro{COVID-19}{Coronavirus Disease 2019}
\acro{COX-2}{cyclo-oxygénase 2}
\acro{CPA}{cellules présentatrices d'antigènes}
\acro{CRP}{C-reactive protein}
\acro{CYP24A1}{24-hydroxylase}
\acro{CYP27B1}{25-hydroxyvitamine D\textsubscript{3}-1α-hydroxylase}
\acro{DBP}{vitamin D binding protein}
\acro{EFSA}{European Food Safety Authority}
\acro{eNOS}{endothelial nitric oxide synthase}
\acro{FDA}{Food and Drugs Administration}
\acro{FGF23}{fibroblast growth factor 23}
\acro{HR}{hazard ratio}
\acro{IC}{intervalle de confiance}
\acro{ICAM-1}{intercellular adhesion molecule 1}
\acro{IFN}{interféron}
\acro{IFN-1}{interférons de type I}
\acro{ifna}[IFN-α]{interféron alpha}
\acro{ifng}[IFN-γ]{interféron gamma}
\acro{IKBa}[IκBα]{inhibitor of nuclear factor kappa-b alpha}
\acro{IKKb}[IKKβ]{IkappaB kinase beta}
\acro{IL-2}{interleukine-2}
\acro{IL-4}{interleukine-4}
\acro{IL-6}{interleukine-6}
\acro{IL-8}{interleukine-8}
\acro{IL-10}{interleukine-10}
\acro{IL-12}{interleukine-12}
\acro{IL-17}{interleukine-17}
\acro{IMC}{indice de masse corporelle}
\acro{iNKT}{invariant NK T cell}
\acro{IOM}{Institute of Medicine}
\acro{LDH}{lactate deshydrogénase}
\acro{LOAEL}{Lowest Observed Adverse Effect Level}
\acro{LPS}{lipopolysaccharide}
\acro{MAPK}{mitogen-activated protein kinases}
\acro{MasR}{récepteur Mas}
\acro{MCP-1}{macrophage chemoattractant protein-1}
\acro{MD}{mean difference}
\acro{MDP}{muramyl dipeptide}
\acro{MIF}{monocyte migration inhibitory factor}
\acro{MIP-1}{macrophage inflammatory protein-1}
\acro{mTORC1}{mechanistic target of rapamycin complex 1}
\acro{nfkb}[NF-κB]{nuclear factor-kappa B}
\acro{NK}{lymphocyte natural killer}
\acro{NO}{oxyde nitrique}
\acro{NOAEL}{Non Observed Adverse Effect Level}
\acro{NOD}{nucleotide-binding oligomerization domain}
\acro{NOD2}{Nucleotide-binding oligomerization domain-containing protein 2}
\acro{NOS}{oxyde nitrique synthase}
\acro{OR}{odds ratio}
\acro{PAFR}{platelet-activating factor receptor}
\acro{PAMP}{pathogen associated molecular pattern}
\acro{PCT}{procalcitonine}
\acro{PRR}{pattern recognition receptor}
\acro{PTH}{parathormone}
\acro{RCT}{randomized control trial}
\acro{RR}{risque relatif}
\acro{RSV}{respiratory syncytial virus}
\acro{RXR}{retinoid X receptor}
\acro{SARS-CoV-2}{Severe Acute Respiratory Syndrome Coronavirus 2}
\acro{SDRA}{syndrome de détresse respiratoire aiguë}
\acro{SLS}{syndrome de libération de cytokines}
\acro{SMD}{standardized mean difference}
\acro{SpO2}[SpO\textsubscript{2}]{saturation pulsée en oxygène}
\acro{SRAA}{système rénine angiotensine aldostérone}
\acro{TCR}{T cell receptor}
\acro{Th}[T helpers]{lymphocytes T helpers}
\acro{Th1}[Th1]{CD4\textsuperscript{+} type 1 helper T cells}
\acro{Th2}[Th2]{CD4\textsuperscript{+} type 2 helper T cells}
\acro{Th17}[Th17]{CD4\textsuperscript{+} type 17 helper T cells}
\acro{TLR}{toll-like receptor}
\acro{Tmax}[T\textsubscript{max}]{temps auquel la C\textsubscript{max} est atteinte}
\acro{tnfa}[TNF-\mupalpha]{tumor necrosis factor alpha}
\acro{Treg}[T\textsubscript{reg}]{lymphocytes T régulateurs}
\acro{TSA}{trial sequencing analysis}
\acro{UI}{unité internationale}
\acro{VDR}{vitamin D receptor}
\acro{VDRE}{\LU{V}{v}itamin D \LU{R}{r}esponse \LU{E}{e}lement}
\end{acronym}
```
